Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

BioIntellisense

Health Tech & Medtech · Denver, United States · Founded 2018 Colt

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$100–500M
Latest valuation · 2026
Unlock exact value
Revenue
$10–50M
Latest reported FY
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Continuous health monitoring and clinical intelligence company with medical-grade wearable devices and Data-as-a-Service

Investors

9 investors on BioIntellisense's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Fresenius Medical Care Balboa II
Jonathan Weiner
Series B+ 7 investors entered at this stage
7wire Ventures
Chimera
UCHealth
Royal Philips
Triple Tree Capital Partners
James Murren
CU Healthcare Innovation Fund

Global footprint

Where BioIntellisense has talent and traffic

AI talent share
4.4% of workforce is AI talent
(4 of 90 staff)
Core AI11.11%
Other AI33.33%
Non-AI workforce8695.56%
Workforce by country
🇺🇸 United States · Denver HQ
Book a demo for the full country breakdown
Web traffic by country
3.8K monthly visits
across markets
🇺🇸 United States92.1%
🇧🇷 Brazil5.3%
🇮🇳 India2.6%
Top 3 markets shown

Sentiment on X

What X is saying about BioIntellisense

An AI-synthesized read of the highest-engagement posts about BioIntellisense on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioIntellisense on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.